HIV-1 and HIV-associated nephropathy 25 years later

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue SUPPL. 1, 2007, Pages

  Wyatt, Christina M ^a   Klotman, Paul E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; DISEASE MODEL; DISEASE TRANSMISSION; DRUG EFFECT; EPIDEMIC; HEALTH; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY; METHODOLOGY; PATHOGENICITY; PATHOLOGY; REVIEW; TREATMENT OUTCOME; VIROLOGY;

AIDS-ASSOCIATED NEPHROPATHY; ANIMALS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE MODELS, ANIMAL; DISEASE OUTBREAKS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY; POPULATION SURVEILLANCE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 34748909990     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03561006     Document Type: Review

References (62)

1. Centers for Disease Control (CDC): Pneumocystis pneumonia - Los Angeles. MMWR Morb Mortal Wkly Rep 30: 250-252, 1981
2. Centers for Disease Control (CDC): Update on Kaposi's sarcoma and opportunistic infections in previously healthy persons - United States. MMWR Morb Mortal Wkly Rep 31: 294, 300-301, 1982
3. Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, Holzman KS, Wormser G, Brettman L, Lange M, Murray HW, Cunningharn-Rundles S: An outbreak of community acquired Pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfunction. N Engl J Med 305: 1431-1438, 1982
4. Centers for Disease Control (CDC): Pneumocystis carinii pneumonia among persons with hemophilia A. MMWR Morb Mortal Wkly Rep 31: 365-367, 1982
5. Centers for Disease Control (CDC): Update on acquired immune defciency syndrome (AIDS) - United States. MMWR Morb Mortal Wkly Rep 31: 507-514, 1982
6. Centers for Disease Control (CDC): Possible transfusion-associated acquired immune deficiency syndrome, AIDS - California. MMWR Morb Mortal Wkly Rep 31: 652-654, 1982
7. Centers for Disease Control (CDC): Unexplained immunodeficiency and opportunistic infections in infants - New York, New Jersey, California. MMWR Morb Mortal Wkly Rep 31: 665-667, 1982
8. Centers for Disease Control (CDC): Immunodeficiency among female sexual partners of males with acquired immune deficiency syndrome (AIDS) - New York. MMWR Morb Mortal Wkly Rep 31: 697-698, 1983
9. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Brun-Vezinet F, Rouzioux C, Rozenbaum W, Montagnier L: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868-871, 1983
10. Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, Mann D, Sidhu GD, Stahl RE, Zolla-Pazner S, Leibowitch J, Popovic M: Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 220: 1865-867, 1983
11. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, et al.: Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224: 500-503, 1984
12. Hahn BH, Shaw GM, Popovic M, Lo Monico A, Gallo RC, Wong-Staal F: Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature 312: 166-169, 1984
13. Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedmann EA: Associated FSGS in AIDS. N Engl J Med 310: 669-673, 1984
14. Gardenschwartz MH, Lerner CW, Seligson GR, Zabetakis PM, Rotterdam H, Tapper ML, Michelis MF, Bruno MS: Renal disease in patients with AIDS: A clinicopathologic study. Clin Nephrol 21: 197-204, 1984
15. Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskowitz L, Hensley GT, Bourgoignie JJ: Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 101: 429-434, 1984
16. Weiss MA, Daquioag E, Margolin EG, Pollak VE: Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": A new clinicopathologic entity. Am J Kidney Dis 7: 20-28, 1986
17. D'Agati V, Suh JI, Carbone L, Cheng JT, Appel G: Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 35: 1358-1370, 1989
18. Carbone L, D'Agati V, Cheng JT, Appel GB: Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 87: 389-395, 1989
19. Cantor ES, Kimmel PL, Bosch JP: Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 151: 125-128, 1991
20. Cohen AH, Sun NC, Shapshak P, Imagawa DT: Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 2: 125-128, 1989
21. Kimmel PL, Ferreira-Centeno A, Farkas-Szallasi T, Abraham AA, Garrett CT: Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int 43: 1347-1352, 1993
22. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, Klotman PE: Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 11: 2079-2087, 2000
23. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 26: 853-860, 1998
24. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089-1093, 1996
25. Stoler MH, Eskin TA, Benn S, Angerer RC, Angerer LM: Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. JAMA 256: 2360-2364, 1986
26. McElrath MJ, Pruett JE, Cohn ZA: Mononuclear phagocytes of blood and bone marrow: Comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci U S A 86: 675-679, 1989
27. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278: 1295-1300, 1997
28. Wong JK, Gunthard HF, Havlir DV, Zhang ZQ, Haase AT, Ignacio CC, Kwok S, Emini E, Richman DD: Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A 94: 12574-12579, 1997
29. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, Notkins AL: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185: 109-119, 1991
30. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100: 84-92, 1997
31. Kajiyama W, Kopp JB, Marinos NJ, Klotman PE, Dickie P: HIV-transgenic mice lacking gag-pol-nef develop glomerulosclerosis and express viral RNA and protein in glomerular epithelial and tubular cells. Kidney Int 58: 1148-1159, 2000
32. Dickie P, Roberts A, Uwiera R, Witmer J, Sharma K, Kopp JB: Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy. Virology 322: 69-81, 2004
33. Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O'Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M, Bryant J: An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98: 9271-9276, 2001
34. Ray PE, Liu X, Robinson LR, Reid W, Xu L, Owens JW, Jones OD, Denaro F, Davis HG, Bryant JL: A novel HIV-1 transgenic rat model of childhood HIV-1 associated nephropathy. Kidney Int 6: 2242-2251, 2003
35. Hanna Z, Kay DG, Cool M, Jothy S, Rebai N, Jolicoeur P: Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like syndrome. J Virology 72: 121-132, 1998
36. Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T: Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 68: 1048-1060, 2005
37. Gharavi AG, Ahmad T, Wong RD, Hooshyar R, Vaughn J, Oller S, Frankel RZ, Bruggeman LA, D'Agati VD, Klotman PE, Lifton RP: Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A 101: 2488-2493, 2004
38. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD: Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS 18: 541-546, 2004
39. Kopp JB, Winkler C: HIV-associated nephropathy in African Americans. Kidney Int 63: 43-49, 2003
40. Freedman BI, Soucie JM, Stone SM, Pegram S: Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 34: 254-258, 1999
41. Selik RM, Byers RH Jr, Dworkin MS: Trends in diseases reported on US death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 29: 378-387, 2002
42. Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE: HAART and the epidemic of HIV+ end stage renal disease. J Am Soc Nephrol 16: 2412-2420, 2005
43. Abbott KC, Hypolite I, Welch PG, Agodoa LY: Human immunodeficiency virus/ acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: Patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol 14: 377-383, 2001
44. UNAIDS 2006 Global Report. Available at: http://www.unaids.org/en/ HIV⊣ta/2006GlobalReport. Accessed September 27, 2006
45. Han TM, Naicker S, Ramdial PK, Assounga AG: A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 69: 2243-2250, 2006
46. Gerntholtz TE, Goetsch SJW, Katz I: HIV-related nephropathy: A South African perspective. Kidney Int 69: 1885-1891, 2006
47. Olson D, Thomas E, Allheimen M, Balkan S, Szumilin E, Humblet P: Impaired renal function of patients initiating HAART in two developing countries [Abstract]. 13th Conference on Retroviruses and Opportunistic Infections, Denver, Colorado, February 5 to 8, 2006
48. Agbaji O, Gwanzhi N, Idoko J: Factors affecting the GFR of ARV-naïve HIV-1-infected patients at the Jos Teaching Hospital, Nigeria [Abstract]. XVI International AIDS Conference, Toronto, Canada, August 13 to 18, 2006
49. Mugabo JS, Lu J, Binagwaho A, Cohen M, Munyakazi L, Ndamage F, d'Adesky AC, Szczech L: Proteinuria, hematuria, and creatinine clearance in Rwandan women with and without HIV infection [Abstract]. XVI International AIDS Conference, Toronto, Canada, August 13 to 18, 2006
50. Reid A, Stohr W, Walker S, Ssali F, Munderi P, Gilks C, on behalf of the DART Trial: Glomerular dysfunction and associated risk factors following initiation of ART in adults with HIV infection in Africa [Abstract]. XVI International AIDS Conference, Toronto, Canada, August 13 to 18, 2006
51. Wali RK, Drachenberg CI, Papadimitriou JC, Keay S, Ramos E: HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 352: 783-784, 1998
52. Winston JA, Bruggeman LA, Ross MD, Jacobson J, Ross L, D'Agati VD, Klotman PE, Klotman ME: Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344: 1979-1984, 2001
53. Szczech LA, Edwards LJ, Sanders LL, van der Horst C, Bartlett JA, Heald AE, Svetky LP: Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol 57: 336-341, 2002
54. Atta MG, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, Scheel PJ, Fine DM: Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 21: 2809-2813, 2006
55. Eustace JA, Nuermberger E, Choi M, Scheel PJ, Moore R, Briggs WA: Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int 58: 1253-1260, 2000
56. Smith MC, Austen JL, Carey JT, Emancipator SN, Herbener T, Gripshover B, Mbanefo C, Phinney M, Rahman M, Salata RA, Weigel K, Kalayjian RC: Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med 101: 41-48, 1996
57. Watterson MK, Detwiler RK, Bolin P: Clinical response to prolonged corticosteroids in a patient with human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 29: 624-626, 1997
58. Ross MJ, Fan C, Ross MD, Chu TT, Shi Y, Kaufman L, Zhang W, Klotman ME, Klotman PE: HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J Acquir Immune Defic Syndr 42: 1-11, 2006
59. Kimmel PL, Mishkin GJ, Umana WO: Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 28: 202-208, 1996
60. Wei A, Burns GC, Williams BA, Mohammed NB, Visintainer P, Sivak SL: Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int 64: 1462-1471, 2003
61. Izzedine H, Launay-Vacher V, Deray G: Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45: 804-817, 2005
62. Wyatt CM, Klotman PE: Antiretroviral therapy and the kidney: Balancing benefit and risk in patients with HIV infection. Expert Opin Drug Saf 5: 275-287, 2006